Tight glycemic control is central to reducing the risk of long-term macrovascular and microvascular complications of type 2 diabetes and the associated morbidity and mortality. Evidence suggests the potential benefits of achieving normoglycemia with early intensive insulin therapy. Once insulin treatment has been initiated, each patient's regimen must be optimized and intensified in order to achieve the HbA1c target of less than 7%. Patient acceptance and adherence to insulin therapy may be improved with step-wise intensification. Dr. Arundhati Dasgupta, Consultant and Director of Diabetes and Endocrinology, joins us LIVE on Medflix to explore potential physician and patient-related hurdles to insulin initiation and intensification, as well as potential strategies to bridge these gaps.

Insulin Initiation & Intensification 

Endocrine emergencies, excluding the common diabetic emergencies, are rare but more significant because of their low incidence. A high level of suspicion is often required to make a diagnosis. However, conditions like myxoedema coma are usually obvious. Often, the physician needs to initiate treatment for these conditions before a confirmed diagnosis. Join us live on Medflix with Dr. Arundhati Dasgupta, who will guide you on the commonly seen endocrine emergencies and the management approach for each of them!

Commonly Reported Endocrine Emergencies & its Management

Consultant Endocrinologist & Diabetologist | Co-Founder of the first comprehensive Endocrinology and Neurology OPD clinic of the region named Rudraksh Superspeciality Care | Director of Diabetes and Endocrinology division of Rudraksh Superspeciality Care.

Dr. Arundhati Dasgupta

2

1.4k

24.8k

4.6

Sessions Taken

702

4.5

659

4.7